LB42708
CAS No. 226929-39-1
LB42708 ( LB42708; LB-42708; LB 42708 )
产品货号. M17445 CAS No. 226929-39-1
LB42708 is an orally active farnesyltransferase (FTase) inhibitor (IC50: 0.8/1.2/2.0 nM toward H/N/K-ras).
纯度: 98%
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
规格 | 价格/人民币 | 库存 | 数量 |
2MG | ¥470 | 有现货 |
|
5MG | ¥713 | 有现货 |
|
10MG | ¥1199 | 有现货 |
|
25MG | ¥2365 | 有现货 |
|
50MG | ¥3532 | 有现货 |
|
100MG | ¥4949 | 有现货 |
|
200MG | 获取报价 | 有现货 |
|
500MG | 获取报价 | 有现货 |
|
1G | 获取报价 | 有现货 |
|
生物学信息
-
产品名称LB42708
-
注意事项本公司产品仅用于科研实验,不得用于人体或动物的临床与诊断
-
产品简述LB42708 is an orally active farnesyltransferase (FTase) inhibitor (IC50: 0.8/1.2/2.0 nM toward H/N/K-ras).
-
产品描述LB42708 is a potent, orally active and selective nonpeptidic farnesyltransferase inhibitor (FTase inhibitor). LB42708 inhibited VEGF-induced Ras activation and subsequently suppressed angiogenesis in vitro and in vivo by blocking the mitogen-activated protein kinase kinase/extracellular signal-regulated kinase/p38 mitogen-activated protein kinase (MAPK) and phosphatidylinositol 3-kinase (PI3K)/Akt/endothelial nitric-oxide synthase pathways in endothelial cells without altering FAK/Src activation.
-
同义词LB42708; LB-42708; LB 42708
-
通路Others
-
靶点Other Targets
-
受体Farnesyl transferase (FTase); Farnesyl transferase (FTase); Farnesyl transferase (FTase)
-
研究领域Cancer
-
适应症——
化学信息
-
CAS Number226929-39-1
-
分子量555.46
-
分子式C30H27BrN4O2
-
纯度98%
-
溶解度——
-
SMILESBrc1ccc(Cn2cncc2Cn2cc(C(=O)N3CCOCC3)c(c2)c2cccc3ccccc23)cc1
-
化学全称(1-((1-(4-bromobenzyl)-1H-imidazol-5-yl)methyl)-4-(naphthalen-1-yl)-1H-pyrrol-3-yl)(morpholino)methanone
运输与储存
-
储存条件(-20℃)
-
运输条件With Ice Pack
-
稳定性≥ 2 years
参考文献
1. Na HJ, et al. J Immunol. 2004, 173(2), 1276-1283.
产品手册
关联产品
-
Emodin-1-O-beta-gent...
Emodin-1-O-beta-gentiobioside is a natural product.
-
Tos-Gly-Pro-Arg-ANBA...
Tos-Gly-Pro-Arg-ANBA-IPA (acetate) is a peptide substrate for luminescence measurement.
-
Euphorbia factor L22
Reference standards. Euphorbia factor L1 analogue.